Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
insulin resistance7794 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A49877 | 35611413 | Turk J Pediatr | Relation of serum irisin levels to obesity and non-alcoholic fatty liver disease. | 2022 | Details |
| A49887 | 35607608 | Diabetes Metab Syndr Obes | Hyperferritinemia Correlates to Metabolic Dysregulation and Steatosis in Chinese Biopsy-Proven Nonalcoholic Fatty Liver Disease Patients. | 2022 | Details |
| A49901 | 35603482 | Hepatology | PAR2 promotes impaired glucose uptake and insulin resistance in NAFLD through GLUT2 and Akt interference. | 2022 | Details |
| A49910 | 35599922 | Ann Gastroenterol | Emerging advances in the pharmacologic treatment of nonalcoholic steatohepatitis and related cirrhosis. | 2022 | Details |
| A49913 | 35598686 | Gene | Metagenomic identification of gut microbiota distribution on the colonic mucosal biopsy samples in patients with non-alcoholic fatty liver disease. | 2022 | Details |
| A49915 | 35598211 | Orv Hetil | A nem alkoholos zsírmájbetegség és a 2-es típusú cukorbetegség. | 2022 | Details |
| A49923 | 35594631 | Nutrition | Concentrated fish oil ameliorates non-alcoholic fatty liver disease by regulating fibroblast growth factor 21-adiponectin axis. | 2022 | Details |
| A49931 | 35590219 | Med (N Y) | Inhibition of ketohexokinase in adults with NAFLD reduces liver fat and inflammatory markers: A randomized phase 2 trial. | 2021 | Details |
| A49933 | 35589613 | Diabetes Obes Metab | Nonalcoholic fatty liver disease and osteoporosis: A potential association with therapeutic implications. | 2022 | Details |
| A49942 | 35586979 | Hepatology | Hepatocellular cystathionine γ lyase/hydrogen sulfide attenuates nonalcoholic fatty liver disease by activating farnesoid X receptor. | 2022 | Details |
| A49955 | 35583480 | J Agric Food Chem | Spermidine Ameliorates Nonalcoholic Steatohepatitis through Thyroid Hormone-Responsive Protein Signaling and the Gut Microbiota-Mediated Metabolism of Bile Acids. | 2022 | Details |
| A49962 | 35581956 | Hepatol Commun | Favorable impact of long-term SGLT2 inhibitor for NAFLD complicated by diabetes mellitus: A 5-year follow-up study. | 2022 | Details |
| A49999 | 35566790 | J Clin Med | Triglyceride-Glucose Index for Early Prediction of Nonalcoholic Fatty Liver Disease: A Meta-Analysis of 121,975 Individuals. | 2022 | Details |
| A50003 | 35565930 | Nutrients | Bifidobacterium animalis ssp. lactis MG741 Reduces Body Weight and Ameliorates Nonalcoholic Fatty Liver Disease via Improving the Gut Permeability and Amelioration of Inflammatory Cytokines. | 2022 | Details |
| A50011 | 35563600 | Int J Mol Sci | Chronic Intermittent Hypoxia Exposure Alternative to Exercise Alleviates High-Fat-Diet-Induced Obesity and Fatty Liver. | 2022 | Details |
| A50013 | 35563534 | Int J Mol Sci | Lipotoxicity as the Leading Cause of Non-Alcoholic Steatohepatitis. | 2022 | Details |
| A50047 | 35546693 | J Coll Physicians Surg Pak | The Relationship Between Lipid Profile and Non-alcoholic Fatty Liver Disease in Children and Adolescents with Obesity. | 2022 | Details |
| A50048 | 35546386 | J Physiol Biochem | The serum uric acid/creatinine ratio is associated with nonalcoholic fatty liver disease in the general population. | 2022 | Details |
| A50049 | 35546181 | Sci Rep | Additional treatment of vitamin D for improvement of insulin resistance in non-alcoholic fatty liver disease patients: a systematic review and meta-analysis. | 2022 | Details |
| A50058 | 35542976 | Ann Palliat Med | A clinical and laboratory-based nomogram for predicting nonalcoholic fatty liver disease in non-diabetic adults: a cross-sectional study. | 2022 | Details |
| A50068 | 35537139 | Food Funct | Corn peptides improved obesity-induced non-alcoholic fatty liver disease through relieving lipid metabolism, insulin resistance and oxidative stress. | 2022 | Details |
| A50079 | 35535063 | J Clin Exp Hepatol | Gallstone Disease in Cirrhosis-Pathogenesis and Management. | 2021 | Details |
| A50080 | 35534573 | Nat Rev Endocrinol | Macrophage functional diversity in NAFLD - more than inflammation. | 2022 | Details |
| A50084 | 35533183 | PLoS One | Insights from a high-fat diet fed mouse model with a humanized liver. | 2022 | Details |
| A50087 | 35532850 | Hormones (Athens) | Menopausal hormone therapy in women with dyslipidemia and nonalcoholic fatty liver disease. | 2022 | Details |
| A50095 | 35528989 | J Clin Transl Hepatol | Glutaminolysis-ammonia-urea Cycle Axis, Non-alcoholic Fatty Liver Disease Progression and Development of Novel Therapies. | 2022 | Details |
| A50096 | 35528987 | J Clin Transl Hepatol | Coagulation and Endothelial Dysfunction Associated with NAFLD: Current Status and Therapeutic Implications. | 2022 | Details |
| A50102 | 35528151 | Acta Clin Croat | CROATIAN GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF NONALCOHOLIC FATTY LIVER DISEASE. | 2021 | Details |
| A50112 | 35521658 | Antioxid Redox Signal | RGS7-ATF3-Tip60 Complex Promotes Hepatic Steatosis and Fibrosis by Directly Inducing TNFα. | 2022 | Details |
| A50115 | 35517895 | Adv Pharm Bull | Protective Role of trans-Chalcone against the Progression from Simple Steatosis to Non-alcoholic Steatohepatitis: Regulation of miR-122, 21, 34a, and 451. | 2021 | Details |
| A50123 | 35512974 | Fertil Steril | Nonalcoholic fatty liver disease and obstructive sleep apnea in women with polycystic ovary syndrome. | 2022 | Details |
| A50127 | 35510379 | J Food Biochem | Major royal jelly proteins alleviate non-alcoholic fatty liver disease in mice model by regulating disordered metabolic pathways. | 2022 | Details |
| A50134 | 35508191 | Am J Physiol Cell Physiol | The role of mitochondria in the pathophysiology and treatment of common metabolic diseases in humans. | 2022 | Details |
| A50137 | 35507279 | Curr Atheroscler Rep | Management of Dyslipidemia in Patients with Non-Alcoholic Fatty Liver Disease. | 2022 | Details |
| A50148 | 35503180 | Adv Exp Med Biol | Manifold Roles of Ceramide Metabolism in Non-Alcoholic Fatty Liver Disease and Liver Cancer. | 2022 | Details |
| A50151 | 35502176 | Evid Based Complement Alternat Med | The Mechanism of Dendrobium officinale as a Treatment for Hyperlipidemia Based on Network Pharmacology and Experimental Validation. | 2022 | Details |
| A50152 | 35501558 | Curr Obes Rep | Hepatocyte Mitochondrial Dynamics and Bioenergetics in Obesity-Related Non-Alcoholic Fatty Liver Disease. | 2022 | Details |
| A50157 | 35500802 | J Ethnopharmacol | Penthorum chinense Pursh. extract attenuates non-alcholic fatty liver disease by regulating gut microbiota and bile acid metabolism in mice. | 2022 | Details |
| A50160 | 35499800 | Biol Trace Elem Res | Selenium-Enriched Probiotic Alleviates Western Diet-Induced Non-alcoholic Fatty Liver Disease in Rats via Modulation of Autophagy Through AMPK/SIRT-1 Pathway. | 2022 | Details |
| A50162 | 35498403 | Front Endocrinol (Lausanne) | Circulating microRNAs Are Associated With Metabolic Markers in Adolescents With Hepatosteatosis. | 2022 | Details |
| A50166 | 35494531 | Diabetes Metab Syndr Obes | Current Perspectives on Nonalcoholic Fatty Liver Disease in Women with Polycystic Ovary Syndrome. | 2022 | Details |
| A50180 | 35487948 | Sci Rep | Hibiscus sabdariffa extract improves hepatic steatosis, partially through IRS-1/Akt and Nrf2 signaling pathways in rats fed a high fat diet. | 2022 | Details |
| A50204 | 35476909 | Angiology | Atherosclerosis and Non-Alcoholic Fatty Liver Disease. | 2022 | Details |
| A50214 | 35471471 | Front Med | Lingguizhugan Decoction, a Chinese herbal formula, improves insulin resistance in overweight/obese subjects with non-alcoholic fatty liver disease: a translational approach. | 2022 | Details |
| A50226 | 35465068 | Gastroenterol Hepatol (N Y) | Nonalcoholic Fatty Liver Disease in Children. | 2021 | Details |
| A50239 | 35462330 | Biomed Pharmacother | Update of Indoles: Promising molecules for ameliorating metabolic diseases. | 2022 | Details |
| A50243 | 35460926 | Biomed J | Prognosis of Chronic Kidney Disease in Patients with Non-Alcoholic Fatty Liver Disease: a Northeastern Taiwan Community Medicine Research Cohort. | 2022 | Details |
| A50248 | 35457142 | Int J Mol Sci | Role of Branched-Chain Amino Acid Metabolism in Type 2 Diabetes, Obesity, Cardiovascular Disease and Non-Alcoholic Fatty Liver Disease. | 2022 | Details |
| A50251 | 35455663 | J Pers Med | Non-Alcoholic Fatty Liver Disease and the Risk of Diabetes Mellitus by Menopausal Status: A Nationwide Cohort Study. | 2022 | Details |
| A50259 | 35451807 | Curr Med Sci | Efficacy of Sitagliptin on Nonalcoholic Fatty Liver Disease in High-fat-diet-fed Diabetic Mice. | 2022 | Details |
| A50268 | 35449197 | Cell Death Discov | HtrA2/Omi mitigates NAFLD in high-fat-fed mice by ameliorating mitochondrial dysfunction and restoring autophagic flux. | 2022 | Details |
| A50274 | 35447548 | Biomed Pharmacother | Downregulation of hepatic fat accumulation, inflammation and fibrosis by nerolidol in purpose built western-diet-induced multiple-hit pathogenesis of NASH animal model. | 2022 | Details |
| A50284 | 35443531 | J Assoc Physicians India | Clinical Characteristics and Metabolic Profiles of Non-Alcoholic Fatty Liver Disease (NAFLD) in Lean Patients and Their Comparison with Obese and Overweight NAFLD. | 2022 | Details |
| A50293 | 35442320 | Arq Gastroenterol | SHOULD ROUTINE LIVER BIOPSY BE CONSIDERED IN BARIATRIC SURGICAL PRACTICE? AN ANALYSIS OF THE LIMITATIONS OF NON-INVASIVE NAFLD MARKERS. | 2022 | Details |
| A50297 | 35440282 | Int J Circumpolar Health | Non-alcoholic fatty liver disease in patients with type 2 diabetes in Greenland: a register-based cross-sectional study. | 2022 | Details |
| A50307 | 35437302 | Panminerva Med | A nutrigenetic tool for precision dietary management of NAFLD deeming insulin resistance markers. | 2022 | Details |
| A50308 | 35436984 | Cell Death Dis | B-cell lymphoma 6 alleviates nonalcoholic fatty liver disease in mice through suppression of fatty acid transporter CD36. | 2022 | Details |
| A50314 | 35436057 | Egypt J Immunol | Role of Thymosin Beta 4 in the diagnosis of Nonalcoholic Fatty Liver and its relation to Metabolic Syndrome in Egyptian patients. | 2022 | Details |
| A50343 | 35428219 | BMC Endocr Disord | Value of the triglyceride glucose index combined with body mass index in identifying non-alcoholic fatty liver disease in patients with type 2 diabetes. | 2022 | Details |
| A50356 | 35420457 | Cannabis Cannabinoid Res | Expanding Research on Cannabis-Based Medicines for Liver Steatosis: A Low-Risk High-Reward Way Out of the Present Deadlock? | 2022 | Details |
| A50359 | 35418240 | Arterioscler Thromb Vasc Biol | Nonalcoholic Fatty Liver Disease and Cardiovascular Risk: A Scientific Statement From the American Heart Association. | 2022 | Details |
| A50361 | 35417923 | Hum Mol Genet | Role of non-coding RNAs on liver metabolism and NAFLD pathogenesis. | 2022 | Details |
| A50365 | 35416741 | Scand J Clin Lab Invest | Nonalcoholic fatty liver disease and its prognosis associates with shorter leucocyte telomeres in a 21-year follow-up study. | 2022 | Details |
| A50366 | 35416649 | J Agric Food Chem | Pterostilbene and Its Derivative 3'-Hydroxypterostilbene Ameliorated Nonalcoholic Fatty Liver Disease Through Synergistic Modulation of the Gut Microbiota and SIRT1/AMPK Signaling Pathway. | 2022 | Details |
| A50377 | 35412016 | Clin Obes | The impact of health status, diet and lifestyle on non-alcoholic fatty liver disease: Narrative review. | 2022 | Details |
| A50381 | 35410857 | Turk J Gastroenterol | Fibroblast Growth Factor 21 as a Marker of Prediabetes in Patients with Non-alcoholic Fatty Liver Disease. | 2022 | Details |
| A50384 | 35409319 | Int J Mol Sci | Hepatic PTEN Signaling Regulates Systemic Metabolic Homeostasis through Hepatokines-Mediated Liver-to-Peripheral Organs Crosstalk. | 2022 | Details |
| A50386 | 35409028 | Int J Mol Sci | SGLT2 Inhibitors as the Most Promising Influencers on the Outcome of Non-Alcoholic Fatty Liver Disease. | 2022 | Details |
| A50391 | 35407014 | Foods | Tilapia-Head Chondroitin Sulfate Protects against Nonalcoholic Fatty Liver Disease via Modulating the Gut-Liver Axis in High-Fat-Diet-Fed C57BL/6 Mice. | 2022 | Details |
| A50394 | 35406631 | Cells | Psoralen Suppresses Lipid Deposition by Alleviating Insulin Resistance and Promoting Autophagy in Oleate-Induced L02 Cells. | 2022 | Details |
| A50395 | 35406066 | Nutrients | Amino Acid-Related Metabolic Signature in Obese Children and Adolescents. | 2022 | Details |
| A50404 | 35403438 | Am J Physiol Endocrinol Metab | Loss of low-molecular-weight protein tyrosine phosphatase shows limited improvement in glucose tolerance but causes mild cardiac hypertrophy in mice. | 2022 | Details |
| A50412 | 35400251 | Crit Rev Food Sci Nutr | Can omega-3 fatty acids be beneficial in pediatric NAFLD? A systematic review and meta-analysis. | 2022 | Details |
| A50419 | 35398502 | J Ethnopharmacol | Integrating metabolomics and network pharmacology to reveal the mechanisms of Delphinium brunonianum extract against nonalcoholic steatohepatitis. | 2022 | Details |
| A50427 | 35396116 | Endocrinol Diabetes Nutr (Engl Ed) | Prevalence and predictors of non-alcoholic steatohepatitis in patients with morbid obesity. | 2022 | Details |
| A50435 | 35393310 | BMJ Open | Multisite prospective Liver Disease and Reproductive Ageing (LIVRA) study in US women living with and without HIV. | 2022 | Details |
| A50436 | 35392825 | BMC Gastroenterol | Steroid-mediated liver steatosis is CD1d-dependent, while steroid-induced liver necrosis, inflammation, and metabolic changes are CD1d-independent. | 2022 | Details |
| A50447 | 35387749 | Eur J Intern Med | Non-alcoholic fatty liver disease: identical etiologic factors in patients with type 1 and type 2 diabetes. | 2022 | Details |
| A50456 | 35384023 | Clin Endocrinol (Oxf) | Relationship between growth hormone deficiency and nonalcoholic fatty liver disease in patients with pituitary stalk interruption syndrome. | 2022 | Details |
| A50463 | 35381388 | Mol Metab | Proteomic analysis reveals exercise training induced remodelling of hepatokine secretion and uncovers syndecan-4 as a regulator of hepatic lipid metabolism. | 2022 | Details |
| A50468 | 35378329 | Mol Metab | Hepatocyte-specific activity of TSC22D4 triggers progressive NAFLD by impairing mitochondrial function. | 2022 | Details |
| A50478 | 35370963 | Front Endocrinol (Lausanne) | The Mechanism Underlying the Influence of Indole-3-Propionic Acid: A Relevance to Metabolic Disorders. | 2022 | Details |
| A50499 | 35363908 | Hepatology | Are there outcome differences between NAFLD and metabolic-associated fatty liver disease? | 2022 | Details |
| A50511 | 35358477 | Biochem Pharmacol | Valdecoxib attenuates lipid-induced hepatic steatosis through autophagy-mediated suppression of endoplasmic reticulum stress. | 2022 | Details |
| A50512 | 35357518 | Naunyn Schmiedebergs Arch Pharmacol | Phytochemicals targeting NAFLD through modulating the dual function of forkhead box O1 (FOXO1) transcription factor signaling pathways. | 2022 | Details |
| A50513 | 35357066 | Liver Int | Impact of a Mediterranean diet on hepatic and metabolic outcomes in non-alcoholic fatty liver disease: The MEDINA randomised controlled trial. | 2022 | Details |
| A50519 | 35354928 | Pediatr Res | LncOb rs10487505 variant is associated with leptin levels in pediatric non-alcoholic fatty liver disease. | 2022 | Details |
| A50523 | 35354619 | BMJ Open | Validation of type 2 diabetes subgroups by simple clinical parameters: a retrospective cohort study of NHANES data from 1999 to 2014. | 2022 | Details |
| A50543 | 35347118 | Cell Death Dis | Hepatic deficiency of selenoprotein S exacerbates hepatic steatosis and insulin resistance. | 2022 | Details |
| A50576 | 35334784 | Nutrients | Added Fructose in Non-Alcoholic Fatty Liver Disease and in Metabolic Syndrome: A Narrative Review. | 2022 | Details |
| A50579 | 35333917 | J Clin Endocrinol Metab | A Simple Test to Identify the Risk of NASH and Cirrhosis in People With Obesity or Diabetes: The Time to Screen Is Now. | 2022 | Details |
| A50584 | 35332833 | Postgrad Med | Noninvasive fibrosis tools in NAFLD: validation of APRI, BARD, FIB-4, NAFLD fibrosis score, and Hepamet fibrosis score in a Portuguese population. | 2022 | Details |
| A50586 | 35332431 | Intern Emerg Med | Antibody to hepatitis B virus core antigen positivity is a predictor of non-alcoholic fatty liver disease severity. | 2022 | Details |
| A50588 | 35332111 | J Obes Metab Syndr | Recent Epidemiology and Risk Factors of Nonalcoholic Fatty Liver Disease. | 2022 | Details |
| A50590 | 35331900 | J Nutr Biochem | Intermittent fasting, high-intensity interval training, or a combination of both have beneficial effects in obese mice with nonalcoholic fatty liver disease. | 2022 | Details |
| A50602 | 35328503 | Int J Mol Sci | The Endocannabinoid System and Physical Activity-A Robust Duo in the Novel Therapeutic Approach against Metabolic Disorders. | 2022 | Details |
| A50611 | 35326230 | Antioxidants (Basel) | Combination Effects of Metformin and a Mixture of Lemon Balm and Dandelion on High-Fat Diet-Induced Metabolic Alterations in Mice. | 2022 | Details |
| A50627 | 35322435 | J Food Biochem | Chia seeds and chemical-elicited sprouts supplementation ameliorates insulin resistance, dyslipidemia, and hepatic steatosis in obese rats. | 2022 | Details |
| A50630 | 35321843 | Clin Res Hepatol Gastroenterol | Effects of dapagliflozin in patients with nonalcoholic fatty liver disease: A systematic review and meta-analysis of randomized controlled trials. | 2022 | Details |
| A50632 | 35320000 | Sci Transl Med | Hepatic IRF3 fuels dysglycemia in obesity through direct regulation of Ppp2r1b. | 2022 | Details |